fbpx

TDR’s U.S. Stock Market Preview For The Week Of September 6, 2022

A weekly stock market preview and the data that will impact the tape.

Sunday Evening Futures Open – Stock Market Preview

Weekend News And Developments

Amazon is reportedly scrapping plans to build dozens of warehouse facilities across the United States amid slowed sales growth. The consulting firm MWPVL says that the online retail giant is either closing or abandoning plans to open 42 facilities across the country totaling almost 25 million square feet of usable space, Bloomberg reported.

Bayer AG agreed to pay $40 million to settle claims over its alleged use of kickbacks and false statements related to three prescription drugs, the U.S. Department of Justice said on Friday.

Bed Bath & Beyond announced that Gustavo Arnal, Executive Vice President and Chief Financial Officer of the Company, passed away on September 2, 2022. The entire Bed Bath & Beyond Inc. organization is profoundly saddened by this shocking loss.

Blade Therapeutics, Inc. announced the presentation of positive data from Phase 1 and preclinical studies of cudetaxestat, an investigational non-competitive autotaxin inhibitor in clinical development for IPF and other fibrotic diseases. The data were featured in a poster presented at the European Respiratory Society (ERS) International Congress 2022, taking place in Barcelona, Spain, from September 4-6, 2022.

Boeing: Israel will ban Boeing 747 and similar aircraft with four engines as of March 31, 2023 to reduce noise and air pollution, its airports authority said on Sunday.

California declared a power grid emergency Monday as a blistering and sustained heat wave threatens to push the state’s electricity system beyond its limit. 

Credit Suisse is considering cutting around 5,000 jobs, about one position in 10, as part of a cost reduction drive at Switzerland’s second-biggest bank, a source with direct knowledge of the matter told Reuters.

Federal Trade Commission filed a notice of appeal in its case challenging Illumina’s multibillion-dollar acquisition of cancer detection company GRAIL.

Gazprom, the Russian energy giant, scrapped its Saturday deadline and indefinitely extended its gas cuts to Europe.

Germany will spend a further 65 billion euros ($64.7 billion) on shielding customers and businesses from soaring inflation, Chancellor Olaf Scholz said on Sunday, two days after Russia announced it was suspending some gas deliveries indefinitely.

Group of Seven industrial nations pledged on Friday to cap the price of Russian oil on global markets. The plan aimed to limit the Kremlin’s revenues and the ability to fund the war in Ukraine, as well as reduce the war’s impact on inflation and energy prices.

Internal Revenue Service mistakenly posted confidential information on its website last week, the Wall Street Journal reported.

Japan’s Universal Entertainment said on Sunday its local representatives in the Philippines have taken over the operations of the Okada Manila gambling resort, the latest step in a long-running ownership dispute.

NASA is postponing its Artemis I launch again, after making a second attempt to get the mission off the ground on Saturday.

Pulmonx Corporation announced the presentation of interim results from the CONVERT Study at the 2022 European Respiratory Society (ERS) International Conference. Data on the first 40 patients in the study demonstrated that treatment with the AeriSeal System successfully converted the collateral ventilation (CV) status in 78% of patients who were subsequently treated with Zephyr Valves.

Russia’s gas supplies to Europe via the Nord Stream 1 pipeline will not resume in full until the “collective west” lifts sanctions against Moscow over its invasion of Ukraine, the Kremlin has said.

Shanghai’s major container port of Yangshan has suspended terminal operations as Typhoon Hinnamnor approaches the east China coast, state media CCTV reported, citing the local maritime authority.

Sweden’s government will provide Nordic and Baltic utilities as much as 250 billion kronor ($23.2 billion) in credit guarantees as it seeks to prevent Russia’s energy curbs from setting off a financial crisis. 

Wendy’s E. coli outbreak spreads to more states, the CDC says. The outbreak is believed to be linked to lettuce at Wendy’s restaurants has spread to New York and Kentucky

Wild summer for meme stocks.

What The Analysts Are Saying…

“I think we have to go back and test that level. “I don’t think the bear market is necessarily over, (though) what I don’t see is a massive decline from here.”Bob Doll, CIO of Crossmark Global Investments of whether on the S&P 500 retesting the 2022 lows

“This data does little to derail the Fed from its current monetary policy path. We call on the Fed to lift the policy rate by 75 basis points, and it should attempt to lift the Federal Funds rate to 4% by the end of the year.”RSM chief economist Joe Brusuelas, after this past week’s solid August jobs report 

“We believe it likely that the United States will struggle to regain above-trend growth in the quarters ahead… We place the likelihood of a U.S. recession at about 25% in the next 12 months and 65% in the next 24 months.”Vanguard Group, September 1

“We see incessant attempts to shift responsibility and blame onto us. We categorically reject this and insist that the collective West – in this case, the EU, Canada, the UK – is to blame for the fact that the situation has reached the point where it is now.”Kremlin spokesman Dmitry Peskov, on the indefinite halt on gas shipments to Europe until sanctions are lifted

👀What We’re Watching👀

Jupiter Neurosciences (NASDAQ:JUNS) scheduled to start trading on September 7 (IPO): Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company that has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. The product candidate, called JOTROL, has many potential indications of use for rare diseases, primarily targeting Mucopolysaccharidoses Type 1, Friedreich’s Ataxia, and MELAS and with ALS in an earlier development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimer’s disease with an early development program in TBI (traumatic brain injury)/concussions.

The company is raising $15 million by issuing 2.5 million shares at between $5.00-7.00 per share. Spartan Capital is acting as the sole book runner for the deal.

Several Non-U.S. Central Banks are meeting
: Several sovereign central banks are meetings to determine whether to raise their benchmark interest rates. The Reserve Bank of AustraliaEuropean Central Bank and the Bank of Canada are all on record ready increase rates as needed to tackle inflation. The ECB is expected to hike rates 75 basis points (although 50 BPs are still in play) while the BoC will meet September 7 to determine how much it hikes (75 basis points is likely).

Name of interest rateCurrent ratePrevious rateLast change
American interest rate FED2.500 %1.750 %07-28-2022
Australian interest rate RBA1.850 %1.350 %08-02-2022
Bank of Korea interest rate2.500 %2.250 %08-25-2022
Brazilian interest rate BACEN13.750 %13.250 %08-04-2022
British interest rate BoE1.750 %1.250 %08-04-2022
Canadian interest rate BOC2.500 %1.500 %07-13-2022
Chinese interest rate PBC3.650 %3.700 %08-22-2022
European interest rate ECB0.500 %0.000 %07-21-2022
Indian interest rate RBI5.400 %4.900 %08-05-2022
Japanese interest rate BoJ-0.100 %0.000 %02-01-2016
Mexican interest rate Banxico8.500 %7.750 %08-11-2022
Russian interest rate CBR8.000 %9.500 %07-22-2022
Saudi Ariabian interest rate3.000 %2.250 %07-27-2022
Swiss interest rate SNB-0.250 %-0.750 %06-16-2022
Turkish interest rate CBRT13.000 %14.000 %08-18-2022

We will be watching to see whether these central banks piggyback or diverge from Jerome Powell’s hawkish disposition at Jackson Hole. For now, most western CBs appear to be firmly following the Fed’s lead while economic indicators remain somewhat stable.

Continuation in the U.S. cannabis sector (MSOS)? After a strong week of Aug. 22, U.S. MSOS and component stocks took a breather last week. with MSOS finishing lower 0.46% even as both the NASDAQ and S&P 500 declined over 3 percent. But with Congress reconvening following the annual summer recess, there appears to be renewed determination to pass federal cannabis legislation before a new Congress sits on January 3, 2023. 

AdvisorShares Pure US Cannabis ETF (MSOS)—Trying to form another higher-low base on the daily chart.

Of course, it could be a case of jawboning by key Democratic Senators which have seen their Cannabis Administration and Opportunity Act fail to garner interest across the isle. But with Republicans threatening to take over the House and Senate in the November midterms, Senate Democrats may have one last chance to attempt to push something through and help an industry that has been stuck in legislative gridlock since Joe Biden was elected president. We view strong price action in MSOS, or a lack thereof, to be the near-term voting mechanism of traders betting on the possibility of reform.

U.S. Economic Calendar

TIME (ET)REPORTPERIODMEDIAN FORECASTPREVIOUS
Monday, Sep. 5
Labor Day holiday. None scheduled.
Tuesday, Sep. 6
9:45 AMS&P U.S. services PMI (final)Aug.44.1
10:00 AMISM services indexAug.55.50%56.7
Wednesday, Sep. 7
8:30 AMInternational trade balanceJuly-$70.1 billion-$79.6 billion
10:00 AMCleveland Fed President Loretta Mester speaks
12:35 PMFed Vice Chair Lael Brainard speaks
2:00 PMBeige Book
2:00 PMFed Vice Chair for Bank Supervision Michael Barr speaksAug.
Thursday, Sep. 8
8:30 AMInitial jobless claimsSept. 3239,000232,000
8:30 AMContinuing jobless claimsAug. 271.44 million
9:10 PMFed Chair Jerome Powell speaks
10:00 AMAverage consumer expenditures2021$61,334
10:00 AMQuarterly services surveyQ2
12 noonChicago Fed President Charles Evans speaks
3:00 PMConsumer creditJuly$40 billion
Friday, Sep. 9
10:00 AMWholesale inventories revisionJuly0.80%
10:00 AMChicago Fed President Charles Evans speaks
12 noonKansas City Fed President Esther George speaks
12 noonFed Gov. Chris Waller speaks

😎Meme Of The Week😎

Key Earnings (US Markets)

DateCompanySymbolEarnings estimate
Monday, August 15Nothing notable
Tuesday, August 16Coupa SoftwareCOUP-$0.23 per share
Guidewire SoftwareGWRE-$0.01
UiPathPATH-$0.11
Wednesday, August 17Academy Sports + OutdoorsASO$2.10
AeroVironmentAVAV$0.12
American EagleAEO$0.14
Casey’s GeneralCASY$3.49
Dave & Buster’sPLAY$1.07
G-III ApparelGIII$0.47
GameStopGME-$0.42
Korn/FerryKFY$1.51
NioNIO-$1.37
REV GroupREVG$0.22
Verint SystemsVRNT$0.53
Thursday, August 18American Outdoor BrandsAOUT$0.08
BilibiliBILI-$4.45
DocuSignDOCU$0.42
FuelCell EnergyFCEL-$0.06
LovesacLOVE$0.47
National BeverageFIZZ$0.55
RHRH$6.62
Smith & Wesson BrandsSWBI$0.21
ZscalerZS$0.21
ZumiezZUMZ$0.47
Friday, August 19ABM IndustriesABM$0.90
KrogerKR$0.79
Source: CNN Business – TDR’s stock market preview sentiment indicator

Past Week What’s Hot… and What’s Not

Top 12 High Short Interest Stocks

TickerCompanyExchangeShortIntFloatS/OIndustry
ICPTIntercept Pharmaceuticals IncNasdaq48.79%23.69M29.80MBiotechnology & Medical Research
BBBYBed Bath & Beyond Inc.Nasdaq40.44%76.05M79.96MRetail (Specialty Non-Apparel)
UPSTUpstart Holdings IncNasdaq37.46%69.40M84.77MConsumer Lending
BIGBig Lots, Inc.NYSE37.09%26.49M28.92MRetailers – Discount Stores
BYNDBeyond Meat IncNasdaq34.35%56.77M63.54MFood Processing
EVGOEvgo IncNasdaq33.99%67.69M69.08MUtilities – Electric
HRTXHeron Therapeutics IncNasdaq33.21%102.38M102.14MBiotechnology & Medical Research
MSTRMicroStrategy IncNasdaq32.82%9.33M9.34MSoftware & Programming
BGFVBig 5 Sporting Goods CorpNasdaq32.11%20.71M22.18MRetailers – Miscellaneous Specialty
WWayfair IncNYSE29.16%70.80M80.51MRetailers – Department Stores
SWTXSpringWorks Therapeutics IncNasdaq28.84%32.22M49.41MBiotechnology & Medical Research
NKLANikola CorporationNasdaq28.12%277.61M433.48MAuto & Truck Manufacturers
Source: highshortinterest.com (data as of August 26) – TDR’ stock market preview, Top 12 High Short Interest Stocks

Tags: stock market preview, stock market preview September 6, 2022.


You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More